Search by Title Article Topic - Any -AdvocacyCertificationClinical TrialsCoronavirusEarly CareerFellowshipFuture LeadersHeart Failure Awareness 365Heart Failure GuidelinesHFSA Annual Scientific MeetingHFSA AwardsHFSA Board Certification ReviewHFSA CommitteesHFSA Comprehensive Heart Failure ReviewHFSA Learning CenterHFSA MembershipIn The NewsIndustryJournal of Cardiac FailureMentorshipNursingPartnersPatient ResourcePodcastsPresident's UpdatesPress ReleaseProfessional DevelopmentProvider EducationResearchSocial MediaSubmissionsWomen in Heart Failure Article Type - Any -HFSA NewsIndustry NewsPatient NewsPractice News Jun 16 2020 | Bayer Extends Clinical Development Program for Finerenone with Phase III Study in Patients with Heart Failure and Preserved Ejection Fraction Industry News Industry Research Read More May 11 2020 | MyoKardia Launches New HCM Disease Awareness Website Industry News Industry Read More May 11 2020 | MyoKardia Announces Primary and All Secondary Endpoints Met in Phase 3 EXPLORER Clinical Trial of Mavacamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy Industry News Industry Read More May 6 2020 | FDA Approves New Treatment For a Type of Heart Failure Industry News Industry Read More Mar 12 2020 | US FDA Grants Fast Track Designation to Jardiance® for the Treatment of Chronic Kidney Disease Practice News Industry FDA Fast Track designation is for the investigation of potential new therapies that treat serious conditions and fulfill an unmet medical need. Read More Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Current page 4 Page 5 Page 6 Page 7 Next page Next › Last page Last »
Jun 16 2020 | Bayer Extends Clinical Development Program for Finerenone with Phase III Study in Patients with Heart Failure and Preserved Ejection Fraction Industry News Industry Research Read More
May 11 2020 | MyoKardia Announces Primary and All Secondary Endpoints Met in Phase 3 EXPLORER Clinical Trial of Mavacamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy Industry News Industry Read More
Mar 12 2020 | US FDA Grants Fast Track Designation to Jardiance® for the Treatment of Chronic Kidney Disease Practice News Industry FDA Fast Track designation is for the investigation of potential new therapies that treat serious conditions and fulfill an unmet medical need. Read More
